Death and destruction of activated T lymphocytes

Immunologic Research

Volumn 19, Issue 2-3, 1999, Pages 143-157

  Crispe, I Nicholas ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspases; Cell cycle control; Death receptors; Liver; Peripheral deletion

Indexed keywords

CASPASE; CD8 ANTIGEN;

APOPTOSIS; CELL CYCLE; IMMUNE RESPONSE; LIVER; LYMPHOCYTE CLONE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0032813876     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786483     Document Type: Review

References (92)

1. Teh H-S, Bennick J, von Boehmer H: Selection of the T cell repertoire during ontogeny: limiting dilution analysis. Eur J Immunol 1982;12:887-892.
2. Jerne NK: The natural selection theory of antibody formation. Proc Natl Acad Sci USA 1955; 41:849-857.
3. Singer GG, Abbas AK: The FAS antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994; 1: 365-372.
4. Butz EA, Bevan MJ: Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 1998;8:167-175.
5. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JDS, et al.: Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998;8:177-187.
6. Leo O, Foo M, Sachs D, Samuelson LE, Bluestone JA: Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci USA 1987;84:1374.
7. Alegre ML, Tso JY, Sattar HA, Smith J, Desalle F, Cole M, et al.: An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity. J Immunol 1995;155: 1544-1555.
8. Henrickson M, Reid J, Bellet JS, Sawchuk SS, Hirsch R: Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR alpha beta (H57-597) and CD3 (145-2C11). Transplantation 1995;60:828-835.
9. Bonnefoy-Berard N, Revillard JP: Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. [Review] [52 refs]. J Heart & Lung Transplantation 1996;15:435-442.
10. Herman A, Kappler JW, Marrack P, Pullen AM: Superantigens: Mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991;9:745-772.
11. + peripheral T cells responding to staphylococcal enterotoxin B in vivo. Eur J Immunol 1991;21:1963-1966.
12. Drake CG, Kotzin BL: Superantigens: Biology, immunology, and potential role in disease. J Clin Immunol 1992; 12:149-162.
13. Huang L, Crispe IN: Superantigen-driven peripheral deletion of T cells. Deletion occurs in cells which have lost the T cell antigen receptor. J Immunol 1993; 151: 1844-1851.
14. Mamalaki C, Tanaka Y, Corbella P, Chandler P, Simpson H, Kioussis D: T cell deletion follows chronic specific T cell activation in vivo. Int Immunol 1993;5: 1285-1292.
15. Huang L, Soldevila G, Leeker M, Flavell RA, Crispe IN: Liver is the site of T cell destruction during peripheral deletion. Immunity 1994;1:741-749.
16. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, et al.: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992; 148: 1274-1279.
17. Crispe IN: Fatal interactions: Fas in mature T cell deletion. Immunity 1994;1:347-349.
18. Smith CA, Farrah T, Goodwin RG: The TNF receptor supoerfamily of cellular and viral proteins: activation, co-stimulation and death. Cell 1994;76:959-962.
19. Itoh N, Nagata S: A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 1993;268: 10,932-10,937.
20. Hsu H, Xiong J, Goeddel DW: The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995; 81:495-504.
21. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenk A, Ni J, et al.: FLICE, a novel FADD-homologous ICE/CED-3- like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85:817-827.
22. Martin SJ, Green DR: Protease activation during apoptosis: death by a thousand cuts? Cell 1995;82: 349-352.
23. Greidinger EL, Miller DK, Yamin TT, Casciola-Rosen L, Rosen A: Sequential activation of three distinct ICE-like activities in Fasligated Jurkat cells. FEBS Lett 1996;390:299-303.
24. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, et al.: Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 1996; 183: 1957-1964.
25. Srinivasula SM, Ahmad M, Fernandez-Alnemri T, Litwack G, Alnemri, ES: Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch-5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA 1996;93: [4486-1449].
26. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S: A caspase-activated DNAse that degrades DNA during apoptosis and its inhibitor ICAD Nature 1998;391:43-50.
27. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, et al.: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76:969-976.
28. Klas C, Debatin K-M, Jonker R, Krammer PH: Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 1993;5:625-630.
29. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, et al.: Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 1996;133:335-343.
30. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356: 314-317.
31. Davidson WF, Dumont FJ, Bedigian HG, Fowlkes BJ, Morse HC, III: Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr and C3H-gld/gld mice. J Immunol 1986;136:4075-4084.
32. Kawabe Y, Ochi A: Programmed cell death and extrathymic reduction of Vβ8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B Nature 1991; 349: 245-247.
33. Scott DE, Kisch WJ, Steinberg AD: Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice. J Immunol 1993;150:664-672.
34. Mchal WZ, Crispe IN: TCR ligation on CD8+ T cells creates double-negative cells in vivo. J Immunol 1998;161:1686-1693.
35. Santoro TJ, Portanova JP, Kotzin BL: The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL- lpr/lpr mice. J Exp Med 1988;167: 1713-1718.
36. Giese T, Davidson W: In CD8+ T cell-deficient lpr/lpr mice, CD4+ B220+ and CD4+B220-T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes. J Immunol 1995;154:4986-4995.
37. Mixter PF, Russell JQ, Durie FH, Budd RC: Decreased CD4-CD8- TCR-alpha-beta + cells in lpr/lpr mice lacking beta 2 microglobulin. J Immunol 1995;154:2063-2067.
38. Sytwu H-K, Liblau RS, McDevitt HO: The Roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996;5:17-30.
39. Mariani SM, Krammer PH: Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Eur J Immunol 1998;28: 1492-1498.
40. Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Ashkenazi, A: Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B Curr Biol 1996;6:1669-1676.
41. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, et al.: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994;163: 1759-1762.
42. Cascino I, Fiucci G, Papoff G, Ruberti G: Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 1995;154:2706-2713.
43. Cascio I, Papoff G, De Maria R, Testi R, Ruberti G: Fas/APO-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J Immunol 1996;156:13-17.
44. Hughes DPM, Crispe IN: A soluble inhibitory isoform of murine Fas generated by alternative splicing. J Exp Med 1995:182: 1395-1401.
45. Hughes DPM, Hayday AJ, Craft JE, Owen MJ, Crispe IN: T cells with gamma delta T cell receptors (TCR) of intestinal type are preferentially expanded in TCR-alpha deficient lpr mice. J Exp Med 1995;182:233-241.
46. Bissonnette RP, Echeverri F, Mahboubi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992;359:552-554.
47. Fraser A, Evan G: A license to kill. [Review] [21 refs]. Cell 1996; 85:781-784.
48. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, et al.: Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992; 149:3753-3758.
49. Boehme SA, Lenardo MJ: Ligand-induced apoptosis of mature T lymphocytes (propriocidal regulation) occurs at distinct stages of the cell cycle. Leukemia 1993;7 Suppl 2:S45-S49.
50. Dao T, Huleatt JW, Hingorani R, Crispe IN: Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle. J Immunol 1997;159:4261-4267.
51. Sherr CJ: Mammalian G1 cyclins. Cell 1993;73:1059-1065.
52. Sherr CJ: The ins and outs of RB Coupling gene expression to the cell cycle clock. Trends Cell Biol 1994;4:15-18.
53. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 cdk-interacting protein Cip-1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;73: 805-816.
54. Polyak K, Lee M, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, et al.: Cloning of p27- kip-1, a cell cycle-dependent kinase inhibitor and a potent mediator of extracellular antimitotic signals. Cell 1994;78:59-66.
55. Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, et al.: Interleukin-2 mediated elimination of p27-kip-1 cyclin dependent kinase inhibitor prevented by rapamycin. Nature 1994;372: 570-573.
56. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR: The p53 network. J Biol Chem 1998; 273: 1-4.
57. Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, et al.: Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 1995; 15:3032-3040.
58. Levkau B, Koyama H, Raines EW, Clurman BE, Herren B, Orth K, et al.: Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Molecular Cell 1998; 1:553-563.
59. Fattman CL, An B, Don QP: Characterization of interior cleavage of retinoblastoma protein in apoptosis. J Cell Biochem 1997;67:399-408.
60. Janicke RU, Walker PA, Lin XY, Porter AG: Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J 1996;15:6969-6978.
61. Haas-Kogan DA, Kogan SC, Levi D, Dazin P, T'Ang A, Ring YK, et al.: Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 1995; 14:461-472.
62. Almasan A, Yin Y, Kelly RE, Lee EY, Bradley A, Li W, et al.: Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci USA 1995;92: 5436-5440.
63. Tan X, Martin SJ, Green DR, Wang JYJ: Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J Biol Chem 1997;272: 9613-9616.
64. Chen WD, Otterson GA, Lipkowitz S, Khleif SN, Coxon AB, Kaye FJ: Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene 1997;14: 1243-1248.
65. Hiebert SW, Packham G, Strom DK, Haffner R, Oren M, Zambetti G: E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol and Cell Biol 1995;15:6864-6874.
66. Kowalik TF, DeGregori J, Schwarz JK, Nevins JR: E2FI overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Virol 1995; 69:2491-2500.
67. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WG, Jr., Livingston DM, et al.: K2F-I functions in mice to promote apoptosis and suppress proliferation. Cell 1996; 85:549-561.
68. Agah R, Kirshenbaum LA, Abdellatif M, Truong LD, Chakraborty S, Michael LH, et al.: Adenoviral delivery of E2F-I directs cell cycle reentry and p53-independent apoplosis in postmitotic adult myocardium in vivo. J Clin Invest 1997; 100: 2722-2728.
69. Shimonkevitz RP, Husmann LA, Bevan MJ, Crispe IN: Transient expression of IL-2 receptor precedes the differentiation of immature thymocytes. Nature 1987; 329:157-159.
70. Crispe IN, Moore MW, Husmann LA, Smith L, Bevan MJ, Shimonkevitz RP: Differentiation potential of subsets of CD4-, CD8- thymocytes. Nature 1987;329:336-339.
71. Poussier P, Edouard P, Lee C, Matthew B, Julius M: Thymus-independent development and negative selection of T cells expressing T cell receptor α/β in the intestinal epithelium: evidence for distinct circulation patterns of gut- and thymus-derived T lymphocytes. J Exp Med 1992;176:187-199.
72. Rocha B, Vassali P, Guy-grand D: Thymic and extrathymic origins of gut intraepithelial lymphocyte populations in mice. J Exp Med 1994; 180:681-686.
73. Lefrancois L, Puddington L: Extrathymic intestinal T-cell development: virtual reality? Immunol Today 1995;16:16-21.
74. Crispe IN Huang L: Neonatal, moribund and undead T cells. The role of the liver in T cell deletion. Semin Immunol 1994;6:39-41.
75. Huang L, Sye K, Crispe IN: Proliferation and apoptosis of abundant B220+ CD4- CD8- T cells in the normal mouse liver. Int Immunol 1994;6:533-540.
76. Geiger T, Gooding LR, Flavell RA: T-cell responsiveness to a peripheral protein and spontaneous autoimmunity in transgenic mice. Proc Natl Acad Sci USA 1992;89:2985-2989.
77. Crispe IN, Mehal WZ: Strange brew: T cells in the liver. Immunol Today 1996;17:522-525.
78. Waek A, Dellaporta P, Crispe IN, Kioussis D: Multiple sites of post-activation CD8+ T cell disposal. Eur J Immunol 1997;27:577-583.
79. Iwakoshi NN, Goldschneider I, Tausche F, Mordes JP, Rossini AA: High frequency apoptosis of recent thymic emigrants in the liver of lymphopenic diabetes-prone BioBreeding rats. J Immunol 1998;160:5838-5850.
80. Tiegs G, Hentschel J, Wendel A: A T cell-dependent experimental liver injury in mice inducible by concanavalin A J Clin Invest 1992; 90:196-203.
81. Gantner F, Leist M, Lohsc AW, Germann PG, Tiegs G: Concanavalin-A induced T cell mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995;21:190-198.
82. Russell JQ, Morrissette GJ, Weidner M, Vyas C, Aleman-Hoey D: Liver damage preferentially results from CD8(+) T cells triggered by high affinity peptide antigens. J Exp Med 1998;188: 1147-1157.
83. Fadok VA, Voelker DR, Camphell PAS, Cohen JJ, Bratton DL, Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by phagocytes. J Immunol 1992; 148:2207-2216.
84. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keelmen RMJ, Pals ST, van der Gers MHJ: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84: 1415-1420.
85. McFarlane IG, McFarlane BM, Major GN, Tolley P, Williams, R: Identification of the hepatic asialoglycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP). Clin Exp Immunol 1984;55:347-354.
86. Dini L, Autuori F, Lentini A, Oliverio S, Piacentini M: The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEBS Lett 1992;296:174-178.
87. Perillo NL, Pace KE, Seilhamer JJ, Baum LG: Apoptosis of T cells mediated by galectin-1. Nature 1995;378:736-739.
88. McNab G, Reeves JL, Salmi M, Hubscher S, Jalkanen S, Adams DH: Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology 1996;110:522-528.
89. Bono P, Salmi M, Smith DJ, Jalkanen S: Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity. J Immunol 1998;160:5563-5571.
90. Myers KJ, Eppihimer MJ, Hall L, Wolitzky B: Interleukin-12- induced adhesion molecule expression in murine liver. Am J Pathol 1998;152:457-468.
91. Pardi R, Bender JR, Dettori C, Giannazza E, Engleman EG: Heterogeneous distribution and transmembrane signaling properties of lymphocyte function-associated antigen (LFA-1) in human lymphocyte subsets. J Immunol 1989; 143:3157-3166.
92. Tao Dao, Mehal WZ, Crispe IN: IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol 1998;161:2217-2222.